🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

Microsoft's Activision acquisition underscores Big Tech's vertical growth strategy

Published 13/10/2023, 17:48
© Reuters.
MSFT
-
AAPL
-
AMZN
-
ATVI
-
META
-

Microsoft (NASDAQ:MSFT)'s recent $69 billion acquisition of Activision Blizzard (NASDAQ:ATVI) underlines the trend of Big Tech companies expanding through vertical transactions, a strategy also adopted by Meta (NASDAQ:META), Apple (NASDAQ:AAPL), and Amazon (NASDAQ:AMZN). This comes despite ongoing efforts by the Federal Trade Commission (FTC) and the Justice Department to curtail such deals, with courts often expressing skepticism towards their arguments.

The FTC continues to contest Microsoft's acquisition, voicing concerns that it could lead to the tech giant dominating the game streaming market. As part of the deal, Microsoft has pledged to make one of Activision’s major game franchises available to other consoles for a decade in an effort to alleviate competition concerns.

This presumption in favor of vertical transactions has been entrenched since the late 1970s. However, President Biden’s top antitrust officials, FTC chair Lina Khan and Justice Department's Jonathan Kanter, have been actively challenging vertical mergers since their appointments in 2021.

In 2017, marking its first attempt to halt a vertical deal in decades, the Justice Department sought to block the $85.4 billion merger between AT&T (NYSE:T) and Time Warner. Despite these initiatives, judges frequently dismiss these challenges due to a perceived lack of evidence.

Microsoft also arrived at a settlement with the European Union, vowing to make Activision titles accessible to competitors in the emerging market for game streaming. This follows unsuccessful attempts by Khan's FTC in 2021 to prevent Nvidia (NASDAQ:NVDA)'s acquisition of Arm and Lockheed Martin’s $4.4 billion purchase of Aerojet Rocketdyne Holdings (NYSE:AJRD). The Justice Department's lawsuit against UnitedHealth (NYSE:UNH) Group’s acquisition of Change Healthcare (NASDAQ:CHNG) was similarly dismissed.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.